Literature DB >> 15828157

Cochlear implants, the deaf culture, and ethics: a study of disability, informed surrogate consent, and ethnocide.

Glenn A Hladek1.   

Abstract

The use of cochlear implants in born-deaf infants addresses the issues of disability, proxy consent, and potential ethnocide of the Deaf culture. The ethical issues explored in this paper are: 1) the disability versus trait argument of deafness, 2) parents versus Deaf community in proxy consent, 3) justification for surgical intervention in a non-life threatening condition, and 4) justification for ethnocide. Decisions for non-competent individuals should be made to assure the child of an open future, with rights that need to be protected now, so that the child can exercise them later as an adult. Cochlear implants provide the potential of an open future and are morally justified on that basis.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Year:  2002        PMID: 15828157     DOI: 10.1007/bf03351265

Source DB:  PubMed          Journal:  Monash Bioeth Rev        ISSN: 1321-2753


  4 in total

1.  Enhancement technology and outcomes: what professionals and researchers can learn from those skeptical about cochlear implants.

Authors:  Patrick Kermit
Journal:  Health Care Anal       Date:  2012-12

Review 2.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

3.  Hearing Beyond the Normal Enabled by Therapeutic Devices: The Role of the Recipient and the Hearing Profession.

Authors:  Gregor Wolbring
Journal:  Neuroethics       Date:  2011-06-01       Impact factor: 1.480

4.  Bioethics and medical/legal considerations on cochlear implants in children.

Authors:  Ivan Dieb Miziara; Carmen Silvia Molleis Galego Miziara; Robson Koji Tsuji; Ricardo Ferreira Bento
Journal:  Braz J Otorhinolaryngol       Date:  2012-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.